Professor Robert MacLaren MD, Professor of Ophthamology, Oxford Eye Hosptial - ‘Developing new genetic treatments for eye disease’
I was first introduced to the concept of gene therapy during experiments performed during my D Phil in the Department of Human Anatomy in the 1990s Gene therapy has since rapidly established itself as a viable treatment for patients with inherited retinal degenerations. In this talk I will outline some challenges we have met in dealing with large genes and genes need to be recoded using codon optimisation. We are currently running several gene therapy trials across a number of centres worldwide. We are also developing other treatments for retinal disease, such as the electronic retina and also a robotic system for operating safely in the back of the eye.
Date:
5 May 2017, 13:00 (Friday, 2nd week, Trinity 2017)
Venue:
Sherrington Building, off Parks Road OX1 3PT
Venue Details:
DPAG, Large Lecture Theatre, Sherrington Building, off South Parks and Parks Road, Oxford OX1 3PT - 01865 272500
Speaker:
Professor Robert MacLaren MD, Professor of Ophthamology (Oxford Eye Hosptial, NDCN, University of Oxford)
Organising department:
Department of Physiology, Anatomy and Genetics (DPAG)
Organiser:
Sarah Noujaim (University of Oxford, Department of Physiology Anatomy and Genetics)
Organiser contact email address:
deborah.goberdhan@dpag.ox.ac.uk
Host:
Professor Deborah Goberdhan (DPAG , University of Oxford)
Part of:
DPAG Head of Department Seminar Series
Topics:
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Sarah Noujaim
